Histamine breakdown: DAO, HNMT & histamine intolerance
N. Thornton, MSc. · Molecular Biologist · 8 min · RARE Labs
Editorially updated:
5 scientific sources · ReferencesHow DAO and HNMT break down histamine, why a DAO blood test cannot establish a diagnosis, and why nutrients do not automatically increase histamine breakdown.
Scientific context, not supplementation advice or a claim about any RARE product. This article does not replace medical advice.
Histamine: a messenger in the body and a food component
Histamine is constantly formed and constantly degraded. It participates in inflammatory responses, gastric acid production, neurotransmission and immune regulation. The problem is therefore not histamine itself, but the balance between formation, release and breakdown.
DAO and HNMT: two different breakdown pathways
Degradation runs along two separate routes. Diamine oxidase (DAO) is a copper-containing amine oxidase that splits histamine and other biogenic amines extracellularly — mainly in the small intestine, but also in the placenta and kidney. Histamine N-methyltransferase (HNMT) works intracellularly: using S-adenosylmethionine as a methyl-group donor, it transfers a methyl group onto histamine. The two routes complement each other, because DAO cannot reach histamine inside the cell and HNMT in turn has no access to extracellular histamine.
DAO blood tests and HNMT: limitations of interpretation
Serum DAO activity varies considerably between individuals. Maintz et al. (2011) described associations between polymorphisms in the DAO gene and serum activity, although individual variants explained only part of the variation. This is another indication that histamine intolerance is not a clearly defined condition with a validated biomarker, but rather a description of a discrepancy between histamine intake or release and degradative capacity.
Structural data exist for HNMT: Horton et al. (2005) described the enzyme's binding pocket and how diverse drugs can inhibit it. This is clinically relevant, because a blocked intracellular breakdown raises tissue histamine — particularly in the central nervous system, where DAO is practically absent and HNMT is the only relevant degradation pathway.
Testing for histamine intolerance: what guidelines recommend →
Histamine intolerance: diet does not explain everything
A common misconception concerns the role of diet. A low-histamine diet mainly reduces exogenous intake from fermented and matured foods. Endogenous release from mast cells is unaffected. Reviews (Maintz & Novak 2007; Comas-Basté et al. 2020) therefore classify histamine intolerance as a transient or persistent discrepancy with multiple possible causes — from enzymatic capacity to drugs that inhibit DAO or HNMT.
Supplements and histamine breakdown: no established shortcut
How physiologically central the DAO route is becomes evident in pregnancy: Maintz et al. (2008) reported in a review that DAO activity rises dramatically during normal pregnancy — presumably to protect the foetus from maternal histamine. The papers cited here do not establish that supplementation with individual nutrients directly increases enzymatic histamine breakdown in humans.
Study design at a glance
- Type
- Evidence overview (biochemistry + observational data)
- Participants
- volunteer and patient cohorts
- Duration
- 2005–2020
What this means — and what it does not
- Histamine is degraded via two separate routes: DAO extracellularly (gut, plasma), HNMT intracellularly (tissues, central nervous system).
- Histamine intolerance describes an imbalance between intake, endogenous release and degradation — not merely a dietary question.
- Serum DAO testing is methodologically disputed; medical evaluation remains important.
- No health claims are authorised for DAO or HNMT in the EU; enzyme preparations replace neither diagnostics nor therapy.
Limitations
- Evidence on histamine intolerance rests mostly on small studies and reviews; validated biomarkers are lacking.
- Serum DAO levels fluctuate widely and correlate poorly with symptoms.
- The role of individual cofactors in enzymatic histamine breakdown in humans is not supported by controlled intervention studies.
- This article provides scientific information and makes no claim about the effect of any RARE product.
Sources
- Maintz L, Novak N, Am J Clin Nutr 2007 — Histamine and histamine intoleranceMaintz L, Novak N · Am J Clin Nutr · 2007 · PMID: 17490952
- Comas-Basté O et al., Biomolecules 2020 — Histamine Intolerance: The Current State of the ArtComas-Basté O, Sánchez-Pérez S, Veciana-Nogués MT et al. · Biomolecules · 2020 · PMID: 32824107
- Maintz L et al., Allergy 2011 — Association of single nucleotide polymorphisms in the diamine oxidase gene with diamine oxidase serum activitiesMaintz L, Yu CF, Rodríguez E et al. · Allergy · 2011 · PMID: 21488903
- Maintz L et al., Hum Reprod Update 2008 — Effects of histamine and diamine oxidase activities on pregnancy: a critical reviewMaintz L, Schwarzer V, Bieber T et al. · Hum Reprod Update · 2008 · PMID: 18499706
- Horton JR et al., J Mol Biol 2005 — Structural basis for inhibition of histamine N-methyltransferase by diverse drugsHorton JR, Sawada K, Nishibori M et al. · J Mol Biol · 2005 · PMID: 16168438
Editorial note: these articles are contextual knowledge pieces and do not replace medical advice.
Our products are foods (food supplements), not medicinal products. They are not intended to prevent, treat or cure any disease. If you have symptoms, pre-existing conditions, are pregnant or breastfeeding, or take medication, please consult your doctor or pharmacist.